Fig. 6 | Laboratory Investigation

Fig. 6

From: Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway

Fig. 6

Clinical relevance of Fezf2-mediated NF-κB activation in human bladder cancer. a Real-time PCR and Western blotting assays showing protein expression of Fezf2, BCL-xL, CCND1, VEGF-C, and nuclear p65 in 10 bladder cancer samples. α-Tubulin and p84 were used as loading controls. b Correlation analysis of Fezf2 and BCL-xL, CCND1, VEGF-C, and nuclear p65 expression. Each bar represents the mean ± SD of three independent experiments

Back to article page